An open, randomised, parallel-group phase III study to compare ZOLADEX 3.6 mg monotherapy with ZOLADEX 3.6 mg + tamoxifen or tamoxifen monotherapy in premenopausal Japanese women with oestrogen-positive breast cancer who had undergone curative resection

Study identifier:ZXBC-1002

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

An open, randomised, parallel-group phase III study to compare ZOLADEX 3.6 mg monotherapy with ZOLADEX 3.6 mg + tamoxifen or tamoxifen monotherapy in premenopausal Japanese women with oestrogen-positive breast cancer who had undergone curative resection

Medical condition

Breast Cancer

Phase

N/A

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Interventional

Age

Date

Study Start Date: 01 Jan 1971

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

"There is no result for the study"

Documents available

Trial Results Summaries
Available here

An open, randomised, parallel-group phase III study to compare ZOLADEX 3.6 mg monotherapy with ZOLADEX 3.6 mg + tamoxifen or tamoxifen monotherapy in premenopausal Japanese women with oestrogen-positive breast cancer who had undergone curative resection

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

Trial Results Summaries